Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus

Clinical and Vaccine Immunology

Volumn 14, Issue 11, 2007, Pages 1532-1535

  Iannacone, Matteo ^a,b   Sitia, Giovanni ^b   Narvaiza, Iñigo ^c   Ruggeri, Zaverio M ^a   Guidotti, Luca G ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; BETA GALACTOSIDASE; CLOPIDOGREL; VIRUS VECTOR;

ADENOVIRUS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; GENE THERAPY; HEMATOCRIT; IMMUNOPATHOLOGY; LEUKOCYTE; LIVER DISEASE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ASPIRIN; DEFECTIVE VIRUSES; IMMUNE SYSTEM DISEASES; LEUKOCYTES; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; PLATELET AGGREGATION INHIBITORS; T-LYMPHOCYTES, CYTOTOXIC; TICLOPIDINE;

EID: 37349096941     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00298-07     Document Type: Article

References (11)

1. Abougergi, M. S., S. J. Gidner, D. K. Spady, B. C. Miller, and D. L. Thiele. 2005. Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection. Hepatology 41:97-105.
2. Cattaneo, M. 2004. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler. Thromb. Vasc. Biol. 24:1980-1987.
3. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
4. Iannacone, M., G. Sitia, M. Isogawa, P. Marchese, M. G. Castro, P. R. Lowenstein, F. V. Chisari, Z. M. Raggeri, and L. G. Guidotti. 2005. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 11:1167-1169.
5. Iannacone, M., G. Sitia, Z. M. Ruggeri, and L. G. Guidotti. 2007. HBV pathogenesis in animal models: recent advances on the role of platelets. J. Hepatol. 46:719-726.
6. Kakimi, K., T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2001. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194:1755-1766.
7. Schmitt, A., J. Guichard, J. M. Masse, N. Debili, and E. M. Cramer. 2001. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp. Hematol. 29:1295-1302.
8. Shering, A. F., D. Bain, K. Stewart, A. L. Epstein, M. G. Castro, G. W. Wilkinson, and P. R. Lowenstein. 1997. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J. Gen. Virol. 78:445-459.
9. Southgate, T. D., P. A. Kingston, and M. G. Castro. 2001. Gene transfer into neural cells in vitro using adenoviral vectors, p. 4.23.1-4.23.40. In J. N. Crawley, C. R. Gerfen, R. McKay, M. A. Rogawski, D. R. Sibley, and P. Skolnick (ed.), Current protocols in neuroscience. John Wiley & Sons, Inc., Hoboken, NJ.
10. Thomas, C. E., E. Abordo-Adesida, T. C. Maleniak, D. Stone, G. Gerdes, and P. R. Lowenstein. 2001. Critical parameters for gene transfer into the brain using adenoviral vectors, p. 4.24.1-4.24.36. In J. N. Crawley, C. R. Gerfen, R. McKay, M. A. Rogawski, D. R. Sibley, and P. Skolnick (ed.), Current protocols in neuroscience. John Wiley & Sons, Hoboken, NJ.
11. Wilson, J. M. 2001. Adenovirus-mediated gene transfer to liver. Adv. Drug Deliv. Rev. 46:205-209.